Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Research Impact Video
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Digital Health and Artificial Intelligence
      • Heart Health
      • Healthy Aging and Mobility
      • Immune System
      • Injury and Rehabilitation
      • Lung Health
      • Mental Health and Substance Use
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Dilawri Cardiovascular Institute
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • M. H. Mohseni Institute of Urologic Sciences
      • Ovarian Cancer Research Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
      • Learning and Development
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
      • CST Cerner
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Indigenous Health Research Unit
      • VCH-VCHRI AI Hub
      • Communications and Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Indigenous Research
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Our Research
  3. Helen Tremlett

Helen Tremlett

Professor
Academic Appointment
Professor
Research Focus
Multiple Sclerosis
Degrees / Designations

PhD

Contact Info
epims.med.ubc.ca/
helen.tremlett@ubc.ca
604-822-0759

Biography

Dr. Helen Tremlett is a professor in the Division of Neurology at the University of British Columbia and Canada Research Chair in Neuroepidemiology and Multiple Sclerosis. She is head of the Tremlett Lab and the Epidemiology in Multiple Sclerosis (MS) research program with the vision of fostering excellence in multi-disciplinary clinical and epidemiological research to advance treatment-related knowledge and improve outcomes in those with MS.

Dr. Tremlett’s research program is funded through operating and foundation grants from the Canadian Institutes of Health Research, the MS Society of Canada, the MS Scientific Research Foundation and the US National MS Society, among others. Ongoing research studies include: the MS prodrome, safety and effectiveness of the disease-modifying drugs for MS; pharmacogenomics; risk of MS in special populations; impact of comorbidities on MS outcomes; and the gut microbiome and MS.

Research Studies

Multiple Sclerosis, Immune System

Multiple Sclerosis, Genes, Microbes, and Medication

News and Awards

Diet and microbiome potentially linked to childhood-onset multiple sclerosis

Nov 12, 2024

Living in wealthier communities decreased death for Canadians with MS

Jun 24, 2023

Heart attack risk found to be higher for people with multiple sclerosis

May 1, 2019

Common treatment for multiple sclerosis may prolong life

Mar 18, 2019

Top Graduating Doctoral Student Award and Rising Star Award 2017 Recipients

May 28, 2017

People in profile: José Wijnands

May 26, 2017

Medical history reveals multiple sclerosis begins to impact patients sooner

Apr 21, 2017

Top Graduating Doctoral Student Award and Rising Star Award 2016 Recipients

Jun 20, 2016

Study examines how MS patients are faring on potentially more effective but also riskier new drugs

Jan 23, 2016

Out of the microbiomes of babes might researchers learn what triggers MS

Dec 5, 2015

Top Graduating Doctoral Student Award and Rising Star Award 2015 Recipients

Apr 13, 2015

Publications

  • The Lancet. Neurology -

    Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort study.

    Wijnands JMA, Kingwell E, Zhu F, Zhao Y, Högg T, Stadnyk K, Ekuma O, Lu X, Evans C, Fisk JD, Marrie RA, Tremlett H
  • JAMA -

    Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis.

    Shirani A, Zhao Y, Karim ME, Evans C, Kingwell E, van der Kop ML, Oger J, Gustafson P, Petkau J, Tremlett H
  • Annals of neurology -

    The gut microbiome in human neurological disease: A review.

    Tremlett H, Bauer KC, Appel-Cresswell S, Finlay BB, Waubant E
  • Nature genetics -

    Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis.

    Kowalec K, Wright GEB, Drögemöller BI, Aminkeng F, Bhavsar AP, Kingwell E, Yoshida EM, Traboulsee A, Marrie RA, Kremenchutzky M, Campbell TL, Duquette P, Chalasani N, Wadelius M, Hallberg P, Xia Z, De Jager PL, Denny JC, Davis MF, Ross CJD, Tremlett H, Carleton BC
  • Brain : a journal of neurology -

    Multiple sclerosis: effect of beta interferon treatment on survival.

    Kingwell E, Leray E, Zhu F, Petkau J, Edan G, Oger J, Tremlett H
Working in the lab

Are you a researcher?

Update or create your researcher profile on our online directory.

Update Profile    Create New Profile

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • LinkedIn
  • X
  • YouTube

© 2025 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy